2
(pooled estimate of the AUC for prediction of 7-day riskϭ0.77; 95% CI, 0.63 to 0.91) scores. 22 In this issue of Stroke, Sheehan et al 23 and Chandratheva et al 24 report the results of 2 independent, relatively large, prospective, population-based studies investigating the diagnostic utility of ABCD 2 for prediction of early stroke risk after TIA. More specifically, Sheehan and colleagues 23 used data from the North Dublin TIA Study (including all TIA cases identified during a 3-year period in a prospective, population-based cohort of 294 529 inhabitants of North Dublin city) to externally validate the ABCD 2 score and to evaluate whether carotid stenosis or atrial fibrillation might add to the prognostic information yielded by the ABCD 2 score. Interestingly, they noted that the degree of carotid stenosis was linearly associated with increased stroke risk after TIA, whereas atrial fibrillation was not. In addition, they documented an agreeable predictive utility of the score in nonspecialist-suspected TIA patients (nϭ700; AUC for prediction of the 90-day riskϭ0.61; 95% CI, 0.52 to 0.71). In contrast, they showed that the predictive ability of the ABCD 2 score was no better than chance in TIA cases confirmed by stroke specialists (nϭ443, AUC for prediction of the 90-day riskϭ0.55; 95% CI, 0.45 to 0.64), largely related to the 24.2% (8/33) of recurrences documented in patients with low ABCD 2 scores. (0 -3) These findings are at odds with the currently supported notion that TIA patients with low ABCD 2 scores carry an insignificant risk of stroke and highlight the importance of emergent carotid evaluation in all TIA patients, independent of the presenting ABCD scores. The main strengths of this timely study are related to the prospective and population-based design, the large sample size, the "hot pursuit" strategy used for TIA identification, and the regular follow-up assessments. On the other hand, certain methodological shortcomings need to be acknowledged: (1) the lack of brain imaging data in a substantial portion of confirmed TIA patients (14.4%); and (2) the absence of a uniform predefined protocol regarding secondary prevention strategies, which were delivered according to the practice of the treating physician and patient preference. Therefore, potential variations in TIA clinical management may have accounted for the higher risk of stroke documented in the low-ABCD 2 -score group who fared poorly. Third, previous investigators have indicated that the ABCD system appears to identify TIA patients with Ն50% carotid artery stenosis or atrial fibrillation who are at high risk of early stroke. 25 However, in the present series, the potential interaction between ABCD 2 score and the degree of carotid artery
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.stenosis in early stroke prediction after TIA was not investigated, whereas the reported hazard ratios depicting the association between carotid artery stenosis and stroke risk were only adjusted for age and sex without taking into account potential confounders, including stroke risk factors and ABCD 2 scores. Chandratheva and colleagues 24 capitalized on the large, prospective, population-based dataset of the Oxford Vascular Study and evaluated the association of ABCD 2 score with stroke severity and recurrent TIAs in a sample of 500 TIA patients collected in a 5-year period in Oxfordshire. They demonstrated that the ABCD 2 score was highly predictive (AUC for prediction of the 7-day riskϭ0.80; 95% CI, 0.72 to 0.87) of major stroke (National Institutes of Health Stroke Scale Score Ͼ3). In contrast, the predictive ability of the score to detect minor stroke after TIA was limited (AUC for prediction of the 7-day riskϭ0.57; 95% CI, 0.43 to 0.71), whereas an inverse relation was documented between ABCD 2 score and risk of recurrent TIAs (ie, with TIA patients presenting with lower ABCD 2 scores being more likely to experience recurrent TIAs). Interestingly, higher ABCD 2 scores predicted not only stroke severity but also strokerelated disability, length of hospitalization for recurrent stroke, and overall acute hospital care costs. These results corroborate current international guidelines 6,7 advocating immediate hospitalization of TIA patients presenting with moderate to high ABCD 2 scores to maximize preventive treatment and facilitate early thrombolysis if a stroke occurs during the first days after a TIA. The main advantages of this elegant study are related to the prospective and population-based design, the thorough methods for TIA identification, the comprehensive statistical analyses, and the strict criteria used for case ascertainment of recurrent strokes and TIAs. The major study limitations are the lack of neuroimaging data in recurrent TIA cases, potential recall bias (TIAs being identified retrospectively by asking presenting stroke patients about recent TIA symptoms), and the absence of any underlying mechanism for the documented inverse association between ABCD 2 score and risk of recurrent TIA. Moreover, given the limited number of minor strokes after TIA (nϭ22), it should be noted that the study may not have been adequately powered to investigate the predictive ability of the score for minor recurrent strokes.
In conclusion, the present 2 studies add to the mounting literature underscoring the importance of emergent diagnostic evaluation and early instigation of secondary prevention strategies in TIA patients in specialist centers that may be associated with a stroke risk reduction by up to 80%. 26, 27 They also highlight the potential (simplicity, applicability, extensive external validation, and both diagnostic and prognostic predictive ability; Table) and failure (inability to take into account stroke and vascular mechanisms, inability to incorporate vascular and brain imaging data; Table) of the newly introduced ABCD 2 score in triaging TIA patients with a high risk of early stroke. Despite its shortcomings, the ABCD 2 score appears to be the best clinical tool available to stratify high-risk TIA patients and may assist in developing admission recommendations in cooperation among neurologists, internists, and emergency department physicians for patients presenting with TIAs. However, it should be kept in mind that the ABCD 2 score has not been developed as a substitute for individualized clinical judgment and that the most important aspect in the optimal management of a TIA patient is not the calculation of the individual score but the accurate identification of the underlying TIA mechanism and vascular pathology.
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